Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Switching to Aripiprazole on Indices of Cardiovascular Health in Overweight and Obese Patients With Schizophrenia

NCT00222833 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00222833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00222833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Switching to Aripiprazole on Indices of Cardiovascular Health in Overweight and Obese Patients With Schizophrenia
Lead sponsor
University of Pittsburgh
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2004
Completion date
December 31, 2005
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, hyperlipidemia, overweight